The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Another Question, Dear Readers

Another Question, Dear Readers

July 1, 2007 • By David S. Pisetsky, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
David S. Pisetsky, MD, PhD

Wow. That’s the first word that came to my mind as I read the responses to my recent “Rheuminations” article about a difficult gout case. The point of my article was that, even with a condition as seemingly simple as gout, complexity intrudes and can wreak havoc with even the established approach to patient care.

You Might Also Like
  • Rheumatology Coding Corner Question: Established Patient Office Visit with Acute Gout
  • Rheumatology Coding Corner Question: Gout Visit for Established Patient
  • Letters to the Editor
Explore This Issue
July 2007
Also By This Author
  • Pisetsky’s Rules vs. the Peltzman Effect

I felt a “wow” quality for several reasons. First and foremost, I was excited that readers took the time to write in and share their opinions. Writing is a lonesome calling and, while I send a blizzard of words into the world on printed pages and the electronic beams of cyberspace, until I get a reply, I live in a vacuum.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Via countless e-mails, I hear regularly from Medscape, lonesome Olga from the frozen steppes of Siberia, and a host of companies hawking products to soup up my ELISAs. While there is some comfort in receiving any email—it is a sign that I am alive and someone thinks I am of value—I really want to hear from you, my readers. Did you like what I wrote? Did my words connect? Did I make sense? I am therefore thrilled by the volume of responses.

To the contributors whose replies are printed on page 8, I say a sincere and heartfelt “thank you” for reading and writing.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

From what I have been reading about the looming disaster on healthcare financing, we should have a “pray-for-performance” initiative.

“Best” Treatment Choice?

The second reason I felt a “wow” quality is the recognition that there are a slew of ways to treat gout in the patient I described. To eliminate any suspense, my preference would be a brief course of glucocorticoids. My preference here is most certainly not evidence-based, primarily because there is no evidence. Rather, I like a course of prednisone because it fits my treatment philosophy (not invasive if I don’t have to be) and, on the occasions where I have had a similar clinical situation, it has worked very well.

Could I have justified a course of adrenocorticotropic hormone (ACTH)? Absolutely. Intra-articular steroids? Sure. Intravenous colchicine? Maybe or maybe not. On the basis of science, I think colchicine would be a great choice—it stops the inflammasome in its tracks—but the literature describes nastiness with this drug. I do not want to ravage the bone marrow for a joint problem that will likely go away by itself.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Crystal Arthritis Tagged With: Gout, Quality, TreatmentIssue: July 2007

You Might Also Like:
  • Rheumatology Coding Corner Question: Established Patient Office Visit with Acute Gout
  • Rheumatology Coding Corner Question: Gout Visit for Established Patient
  • Letters to the Editor
  • Ethics Forum: Letters from our Readers

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)